Table of Content

1 Report Overview
1.1 Montelukast Drug Definition
1.2 Market by Type
1.2.1 Global Montelukast Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Tablets
1.2.3 Oral Granules
1.3 Market Segment by Application
1.3.1 Global Montelukast Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Montelukast Drug Sales
2.1 Global Montelukast Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Montelukast Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Montelukast Drug Revenue by Region
2.3.1 Global Montelukast Drug Revenue by Region (2018-2023)
2.3.2 Global Montelukast Drug Revenue by Region (2024-2034)
2.4 Global Montelukast Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Montelukast Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Montelukast Drug Sales Quantity by Region
2.6.1 Global Montelukast Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Montelukast Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Montelukast Drug Sales Quantity by Manufacturers
3.1.1 Global Montelukast Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Montelukast Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Montelukast Drug Sales in 2024
3.2 Global Montelukast Drug Revenue by Manufacturers
3.2.1 Global Montelukast Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Montelukast Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Montelukast Drug Revenue in 2024
3.3 Global Montelukast Drug Sales Price by Manufacturers
3.4 Global Key Players of Montelukast Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Montelukast Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Montelukast Drug, Product Offered and Application
3.8 Global Key Manufacturers of Montelukast Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Montelukast Drug Sales Quantity by Type
4.1.1 Global Montelukast Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Montelukast Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Montelukast Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Montelukast Drug Revenue by Type
4.2.1 Global Montelukast Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Montelukast Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Montelukast Drug Revenue Market Share by Type (2018-2034)
4.3 Global Montelukast Drug Price by Type
4.3.1 Global Montelukast Drug Price by Type (2018-2023)
4.3.2 Global Montelukast Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Montelukast Drug Sales Quantity by Application
5.1.1 Global Montelukast Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Montelukast Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Montelukast Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Montelukast Drug Revenue by Application
5.2.1 Global Montelukast Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Montelukast Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Montelukast Drug Revenue Market Share by Application (2018-2034)
5.3 Global Montelukast Drug Price by Application
5.3.1 Global Montelukast Drug Price by Application (2018-2023)
5.3.2 Global Montelukast Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Montelukast Drug Sales by Company
6.1.1 North America Montelukast Drug Revenue by Company (2018-2023)
6.1.2 North America Montelukast Drug Sales Quantity by Company (2018-2023)
6.2 North America Montelukast Drug Market Size by Type
6.2.1 North America Montelukast Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Montelukast Drug Revenue by Type (2018-2034)
6.3 North America Montelukast Drug Market Size by Application
6.3.1 North America Montelukast Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Montelukast Drug Revenue by Application (2018-2034)
6.4 North America Montelukast Drug Market Size by Country
6.4.1 North America Montelukast Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Montelukast Drug Revenue by Country (2018-2034)
6.4.3 North America Montelukast Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Montelukast Drug Sales by Company
7.1.1 Europe Montelukast Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Montelukast Drug Revenue by Company (2018-2023)
7.2 Europe Montelukast Drug Market Size by Type
7.2.1 Europe Montelukast Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Montelukast Drug Revenue by Type (2018-2034)
7.3 Europe Montelukast Drug Market Size by Application
7.3.1 Europe Montelukast Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Montelukast Drug Revenue by Application (2018-2034)
7.4 Europe Montelukast Drug Market Size by Country
7.4.1 Europe Montelukast Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Montelukast Drug Revenue by Country (2018-2034)
7.4.3 Europe Montelukast Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Montelukast Drug Sales by Company
8.1.1 China Montelukast Drug Sales Quantity by Company (2018-2023)
8.1.2 China Montelukast Drug Revenue by Company (2018-2023)
8.2 China Montelukast Drug Market Size by Type
8.2.1 China Montelukast Drug Sales Quantity by Type (2018-2034)
8.2.2 China Montelukast Drug Revenue by Type (2018-2034)
8.3 China Montelukast Drug Market Size by Application
8.3.1 China Montelukast Drug Sales Quantity by Application (2018-2034)
8.3.2 China Montelukast Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Montelukast Drug Sales by Company
9.1.1 APAC Montelukast Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Montelukast Drug Revenue by Company (2018-2023)
9.2 APAC Montelukast Drug Market Size by Type
9.2.1 APAC Montelukast Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Montelukast Drug Revenue by Type (2018-2034)
9.3 APAC Montelukast Drug Market Size by Application
9.3.1 APAC Montelukast Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Montelukast Drug Revenue by Application (2018-2034)
9.4 APAC Montelukast Drug Market Size by Region
9.4.1 APAC Montelukast Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Montelukast Drug Revenue by Region (2018-2034)
9.4.3 APAC Montelukast Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Montelukast Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Montelukast Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Montelukast Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Montelukast Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Montelukast Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Montelukast Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Montelukast Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Montelukast Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Montelukast Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Information
11.1.2 Merck & Co. Overview
11.1.3 Merck & Co. Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Merck & Co. Montelukast Drug Products and Services
11.1.5 Merck & Co. Montelukast Drug SWOT Analysis
11.1.6 Merck & Co. Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Teva Montelukast Drug Products and Services
11.2.5 Teva Montelukast Drug SWOT Analysis
11.2.6 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Mylan Montelukast Drug Products and Services
11.3.5 Mylan Montelukast Drug SWOT Analysis
11.3.6 Mylan Recent Developments
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Company Information
11.4.2 Glenmark Pharmaceuticals Overview
11.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Glenmark Pharmaceuticals Montelukast Drug Products and Services
11.4.5 Glenmark Pharmaceuticals Montelukast Drug SWOT Analysis
11.4.6 Glenmark Pharmaceuticals Recent Developments
11.5 Hikma Group
11.5.1 Hikma Group Company Information
11.5.2 Hikma Group Overview
11.5.3 Hikma Group Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Hikma Group Montelukast Drug Products and Services
11.5.5 Hikma Group Montelukast Drug SWOT Analysis
11.5.6 Hikma Group Recent Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Overview
11.6.3 Sandoz Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Sandoz Montelukast Drug Products and Services
11.6.5 Sandoz Montelukast Drug SWOT Analysis
11.6.6 Sandoz Recent Developments
11.7 Torrent Pharmaceuticals
11.7.1 Torrent Pharmaceuticals Company Information
11.7.2 Torrent Pharmaceuticals Overview
11.7.3 Torrent Pharmaceuticals Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Torrent Pharmaceuticals Montelukast Drug Products and Services
11.7.5 Torrent Pharmaceuticals Montelukast Drug SWOT Analysis
11.7.6 Torrent Pharmaceuticals Recent Developments
11.8 Lannett Company
11.8.1 Lannett Company Company Information
11.8.2 Lannett Company Overview
11.8.3 Lannett Company Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Lannett Company Montelukast Drug Products and Services
11.8.5 Lannett Company Montelukast Drug SWOT Analysis
11.8.6 Lannett Company Recent Developments
11.9 Apotex
11.9.1 Apotex Company Information
11.9.2 Apotex Overview
11.9.3 Apotex Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Apotex Montelukast Drug Products and Services
11.9.5 Apotex Montelukast Drug SWOT Analysis
11.9.6 Apotex Recent Developments
11.10 Dr. Reddys Laboratories
11.10.1 Dr. Reddys Laboratories Company Information
11.10.2 Dr. Reddys Laboratories Overview
11.10.3 Dr. Reddys Laboratories Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Dr. Reddys Laboratories Montelukast Drug Products and Services
11.10.5 Dr. Reddys Laboratories Montelukast Drug SWOT Analysis
11.10.6 Dr. Reddys Laboratories Recent Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Information
11.11.2 Aurobindo Pharma Overview
11.11.3 Aurobindo Pharma Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Aurobindo Pharma Montelukast Drug Products and Services
11.11.5 Aurobindo Pharma Recent Developments
11.12 Accord Healthcare
11.12.1 Accord Healthcare Company Information
11.12.2 Accord Healthcare Overview
11.12.3 Accord Healthcare Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Accord Healthcare Montelukast Drug Products and Services
11.12.5 Accord Healthcare Recent Developments
11.13 Hetero
11.13.1 Hetero Company Information
11.13.2 Hetero Overview
11.13.3 Hetero Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Hetero Montelukast Drug Products and Services
11.13.5 Hetero Recent Developments
11.14 Unimark
11.14.1 Unimark Company Information
11.14.2 Unimark Overview
11.14.3 Unimark Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Unimark Montelukast Drug Products and Services
11.14.5 Unimark Recent Developments
11.15 Ajanta Pharma
11.15.1 Ajanta Pharma Company Information
11.15.2 Ajanta Pharma Overview
11.15.3 Ajanta Pharma Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 Ajanta Pharma Montelukast Drug Products and Services
11.15.5 Ajanta Pharma Recent Developments
11.16 MACLEODS
11.16.1 MACLEODS Company Information
11.16.2 MACLEODS Overview
11.16.3 MACLEODS Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 MACLEODS Montelukast Drug Products and Services
11.16.5 MACLEODS Recent Developments
11.17 Jubilant Pharma
11.17.1 Jubilant Pharma Company Information
11.17.2 Jubilant Pharma Overview
11.17.3 Jubilant Pharma Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.17.4 Jubilant Pharma Montelukast Drug Products and Services
11.17.5 Jubilant Pharma Recent Developments
11.18 Unichem Laboratories
11.18.1 Unichem Laboratories Company Information
11.18.2 Unichem Laboratories Overview
11.18.3 Unichem Laboratories Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.18.4 Unichem Laboratories Montelukast Drug Products and Services
11.18.5 Unichem Laboratories Recent Developments
11.19 Amneal Pharmaceuticals
11.19.1 Amneal Pharmaceuticals Company Information
11.19.2 Amneal Pharmaceuticals Overview
11.19.3 Amneal Pharmaceuticals Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.19.4 Amneal Pharmaceuticals Montelukast Drug Products and Services
11.19.5 Amneal Pharmaceuticals Recent Developments
11.20 Shanghai Anbison Lab
11.20.1 Shanghai Anbison Lab Company Information
11.20.2 Shanghai Anbison Lab Overview
11.20.3 Shanghai Anbison Lab Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.20.4 Shanghai Anbison Lab Montelukast Drug Products and Services
11.20.5 Shanghai Anbison Lab Recent Developments
11.21 Perrigo
11.21.1 Perrigo Company Information
11.21.2 Perrigo Overview
11.21.3 Perrigo Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.21.4 Perrigo Montelukast Drug Products and Services
11.21.5 Perrigo Recent Developments
11.22 Cipla
11.22.1 Cipla Company Information
11.22.2 Cipla Overview
11.22.3 Cipla Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.22.4 Cipla Montelukast Drug Products and Services
11.22.5 Cipla Recent Developments
11.23 CSPC Ouyi Pharmaceutical
11.23.1 CSPC Ouyi Pharmaceutical Company Information
11.23.2 CSPC Ouyi Pharmaceutical Overview
11.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Products and Services
11.23.5 CSPC Ouyi Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Montelukast Drug Value Chain Analysis
12.2 Montelukast Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Montelukast Drug Production Mode & Process
12.4 Montelukast Drug Sales and Marketing
12.4.1 Montelukast Drug Sales Channels
12.4.2 Montelukast Drug Distributors
12.5 Montelukast Drug Customers
13 Market Dynamics
13.1 Montelukast Drug Industry Trends
13.2 Montelukast Drug Market Drivers
13.3 Montelukast Drug Market Challenges
13.4 Montelukast Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Montelukast Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Oral Granules
Table 4. Global Montelukast Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Montelukast Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Montelukast Drug Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Montelukast Drug Revenue Market Share by Region (2018-2023)
Table 8. Global Montelukast Drug Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Montelukast Drug Revenue Market Share by Region (2024-2034)
Table 10. Global Montelukast Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Montelukast Drug Sales by Region (2018-2023) & (K Units)
Table 12. Global Montelukast Drug Sales Market Share by Region (2018-2023)
Table 13. Global Montelukast Drug Sales by Region (2024-2034) & (K Units)
Table 14. Global Montelukast Drug Sales Market Share by Region (2024-2034)
Table 15. Global Montelukast Drug Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Montelukast Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Montelukast Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Montelukast Drug Revenue Share by Manufacturers (2018-2023)
Table 19. Global Montelukast Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Montelukast Drug, Industry Ranking, 2021 VS 2024
Table 21. Global Montelukast Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Montelukast Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Montelukast Drug as of 2024)
Table 23. Global Key Manufacturers of Montelukast Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Montelukast Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Montelukast Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Montelukast Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Montelukast Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Montelukast Drug Sales Quantity Share by Type (2018-2023)
Table 30. Global Montelukast Drug Sales Quantity Share by Type (2024-2034)
Table 31. Global Montelukast Drug Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Montelukast Drug Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Montelukast Drug Revenue Share by Type (2018-2023)
Table 34. Global Montelukast Drug Revenue Share by Type (2024-2034)
Table 35. Montelukast Drug Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Montelukast Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Montelukast Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Montelukast Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Montelukast Drug Sales Quantity Share by Application (2018-2023)
Table 40. Global Montelukast Drug Sales Quantity Share by Application (2024-2034)
Table 41. Global Montelukast Drug Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Montelukast Drug Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Montelukast Drug Revenue Share by Application (2018-2023)
Table 44. Global Montelukast Drug Revenue Share by Application (2024-2034)
Table 45. Montelukast Drug Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Montelukast Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Montelukast Drug Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Montelukast Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Montelukast Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Montelukast Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Montelukast Drug Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Montelukast Drug Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Montelukast Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Montelukast Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Montelukast Drug Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Montelukast Drug Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Montelukast Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Montelukast Drug Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Montelukast Drug Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Montelukast Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Montelukast Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Montelukast Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Montelukast Drug Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Montelukast Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Montelukast Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Montelukast Drug Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Montelukast Drug Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Montelukast Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Montelukast Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Montelukast Drug Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Montelukast Drug Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Montelukast Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Montelukast Drug Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Montelukast Drug Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Montelukast Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Montelukast Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Montelukast Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Montelukast Drug Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Montelukast Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Montelukast Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Montelukast Drug Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Montelukast Drug Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Montelukast Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Montelukast Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Montelukast Drug Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Montelukast Drug Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Montelukast Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Montelukast Drug Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Montelukast Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Montelukast Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Montelukast Drug Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Montelukast Drug Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Montelukast Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Montelukast Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Montelukast Drug Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Montelukast Drug Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Montelukast Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Montelukast Drug Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Montelukast Drug Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Montelukast Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Montelukast Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Montelukast Drug Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Montelukast Drug Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Montelukast Drug Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Montelukast Drug Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Montelukast Drug Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Montelukast Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Montelukast Drug Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Montelukast Drug Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Montelukast Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Merck & Co. Company Information
Table 118. Merck & Co. Description and Overview
Table 119. Merck & Co. Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. Merck & Co. Montelukast Drug Product and Services
Table 121. Merck & Co. Montelukast Drug SWOT Analysis
Table 122. Merck & Co. Recent Developments
Table 123. Teva Company Information
Table 124. Teva Description and Overview
Table 125. Teva Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. Teva Montelukast Drug Product and Services
Table 127. Teva Montelukast Drug SWOT Analysis
Table 128. Teva Recent Developments
Table 129. Mylan Company Information
Table 130. Mylan Description and Overview
Table 131. Mylan Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. Mylan Montelukast Drug Product and Services
Table 133. Mylan Montelukast Drug SWOT Analysis
Table 134. Mylan Recent Developments
Table 135. Glenmark Pharmaceuticals Company Information
Table 136. Glenmark Pharmaceuticals Description and Overview
Table 137. Glenmark Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. Glenmark Pharmaceuticals Montelukast Drug Product and Services
Table 139. Glenmark Pharmaceuticals Montelukast Drug SWOT Analysis
Table 140. Glenmark Pharmaceuticals Recent Developments
Table 141. Hikma Group Company Information
Table 142. Hikma Group Description and Overview
Table 143. Hikma Group Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. Hikma Group Montelukast Drug Product and Services
Table 145. Hikma Group Montelukast Drug SWOT Analysis
Table 146. Hikma Group Recent Developments
Table 147. Sandoz Company Information
Table 148. Sandoz Description and Overview
Table 149. Sandoz Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. Sandoz Montelukast Drug Product and Services
Table 151. Sandoz Montelukast Drug SWOT Analysis
Table 152. Sandoz Recent Developments
Table 153. Torrent Pharmaceuticals Company Information
Table 154. Torrent Pharmaceuticals Description and Overview
Table 155. Torrent Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Torrent Pharmaceuticals Montelukast Drug Product and Services
Table 157. Torrent Pharmaceuticals Montelukast Drug SWOT Analysis
Table 158. Torrent Pharmaceuticals Recent Developments
Table 159. Lannett Company Company Information
Table 160. Lannett Company Description and Overview
Table 161. Lannett Company Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. Lannett Company Montelukast Drug Product and Services
Table 163. Lannett Company Montelukast Drug SWOT Analysis
Table 164. Lannett Company Recent Developments
Table 165. Apotex Company Information
Table 166. Apotex Description and Overview
Table 167. Apotex Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 168. Apotex Montelukast Drug Product and Services
Table 169. Apotex Montelukast Drug SWOT Analysis
Table 170. Apotex Recent Developments
Table 171. Dr. Reddys Laboratories Company Information
Table 172. Dr. Reddys Laboratories Description and Overview
Table 173. Dr. Reddys Laboratories Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 174. Dr. Reddys Laboratories Montelukast Drug Product and Services
Table 175. Dr. Reddys Laboratories Montelukast Drug SWOT Analysis
Table 176. Dr. Reddys Laboratories Recent Developments
Table 177. Aurobindo Pharma Company Information
Table 178. Aurobindo Pharma Description and Overview
Table 179. Aurobindo Pharma Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 180. Aurobindo Pharma Montelukast Drug Product and Services
Table 181. Aurobindo Pharma Recent Developments
Table 182. Accord Healthcare Company Information
Table 183. Accord Healthcare Description and Overview
Table 184. Accord Healthcare Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 185. Accord Healthcare Montelukast Drug Product and Services
Table 186. Accord Healthcare Recent Developments
Table 187. Hetero Company Information
Table 188. Hetero Description and Overview
Table 189. Hetero Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 190. Hetero Montelukast Drug Product and Services
Table 191. Hetero Recent Developments
Table 192. Unimark Company Information
Table 193. Unimark Description and Overview
Table 194. Unimark Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 195. Unimark Montelukast Drug Product and Services
Table 196. Unimark Recent Developments
Table 197. Ajanta Pharma Company Information
Table 198. Ajanta Pharma Description and Overview
Table 199. Ajanta Pharma Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 200. Ajanta Pharma Montelukast Drug Product and Services
Table 201. Ajanta Pharma Recent Developments
Table 202. MACLEODS Company Information
Table 203. MACLEODS Description and Overview
Table 204. MACLEODS Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 205. MACLEODS Montelukast Drug Product and Services
Table 206. MACLEODS Recent Developments
Table 207. Jubilant Pharma Company Information
Table 208. Jubilant Pharma Description and Overview
Table 209. Jubilant Pharma Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 210. Jubilant Pharma Montelukast Drug Product and Services
Table 211. Jubilant Pharma Recent Developments
Table 212. Unichem Laboratories Company Information
Table 213. Unichem Laboratories Description and Overview
Table 214. Unichem Laboratories Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 215. Unichem Laboratories Montelukast Drug Product and Services
Table 216. Unichem Laboratories Recent Developments
Table 217. Amneal Pharmaceuticals Company Information
Table 218. Amneal Pharmaceuticals Description and Overview
Table 219. Amneal Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 220. Amneal Pharmaceuticals Montelukast Drug Product and Services
Table 221. Amneal Pharmaceuticals Recent Developments
Table 222. Shanghai Anbison Lab Company Information
Table 223. Shanghai Anbison Lab Description and Overview
Table 224. Shanghai Anbison Lab Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 225. Shanghai Anbison Lab Montelukast Drug Product and Services
Table 226. Shanghai Anbison Lab Recent Developments
Table 227. Perrigo Company Information
Table 228. Perrigo Description and Overview
Table 229. Perrigo Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 230. Perrigo Montelukast Drug Product and Services
Table 231. Perrigo Recent Developments
Table 232. Cipla Company Information
Table 233. Cipla Description and Overview
Table 234. Cipla Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 235. Cipla Montelukast Drug Product and Services
Table 236. Cipla Recent Developments
Table 237. CSPC Ouyi Pharmaceutical Company Information
Table 238. CSPC Ouyi Pharmaceutical Description and Overview
Table 239. CSPC Ouyi Pharmaceutical Montelukast Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 240. CSPC Ouyi Pharmaceutical Montelukast Drug Product and Services
Table 241. CSPC Ouyi Pharmaceutical Recent Developments
Table 242. Key Raw Materials Lists
Table 243. Raw Materials Key Suppliers Lists
Table 244. Montelukast Drug Distributors List
Table 245. Montelukast Drug Customers List
Table 246. Montelukast Drug Market Trends
Table 247. Montelukast Drug Market Drivers
Table 248. Montelukast Drug Market Challenges
Table 249. Montelukast Drug Market Restraints
Table 250. Research Programs/Design for This Report
Table 251. Key Data Information from Secondary Sources
Table 252. Key Data Information from Primary Sources
List of Figures
Figure 1. Montelukast Drug Product Picture
Figure 2. Global Montelukast Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Montelukast Drug Market Share by Type in 2024 & 2034
Figure 4. Tablets Product Picture
Figure 5. Oral Granules Product Picture
Figure 6. Global Montelukast Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Montelukast Drug Market Share by Application in 2024 & 2034
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Others
Figure 11. Montelukast Drug Report Years Considered
Figure 12. Global Montelukast Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Montelukast Drug Revenue 2018-2034 (US$ Million)
Figure 14. Global Montelukast Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global Montelukast Drug Sales Quantity 2018-2034 (K Units)
Figure 16. Global Montelukast Drug Sales Quantity Market Share by Region (2018-2023)
Figure 17. Global Montelukast Drug Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Montelukast Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Montelukast Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Montelukast Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Montelukast Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Montelukast Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Montelukast Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Montelukast Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Montelukast Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Montelukast Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Montelukast Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Montelukast Drug Sales Quantity in 2024
Figure 29. The Top 10 and Top 5 Players Market Share by Montelukast Drug Revenue in 2024
Figure 30. Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global Montelukast Drug Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Montelukast Drug Revenue Market Share by Type (2018-2034)
Figure 33. Global Montelukast Drug Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Montelukast Drug Revenue Market Share by Application (2018-2034)
Figure 35. North America Montelukast Drug Revenue Market Share by Company in 2024
Figure 36. North America Montelukast Drug Sales Quantity Market Share by Company in 2024
Figure 37. North America Montelukast Drug Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Montelukast Drug Revenue Market Share by Type (2018-2034)
Figure 39. North America Montelukast Drug Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Montelukast Drug Revenue Market Share by Application (2018-2034)
Figure 41. North America Montelukast Drug Revenue Share by Country (2018-2034)
Figure 42. North America Montelukast Drug Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Montelukast Drug Sales Quantity Market Share by Company in 2024
Figure 46. Europe Montelukast Drug Revenue Market Share by Company in 2024
Figure 47. Europe Montelukast Drug Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Montelukast Drug Revenue Market Share by Type (2018-2034)
Figure 49. Europe Montelukast Drug Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Montelukast Drug Revenue Market Share by Application (2018-2034)
Figure 51. Europe Montelukast Drug Revenue Share by Country (2018-2034)
Figure 52. Europe Montelukast Drug Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 54. France Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 58. China Montelukast Drug Sales Quantity Market Share by Company in 2024
Figure 59. China Montelukast Drug Revenue Market Share by Company in 2024
Figure 60. China Montelukast Drug Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Montelukast Drug Revenue Market Share by Type (2018-2034)
Figure 62. China Montelukast Drug Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Montelukast Drug Revenue Market Share by Application (2018-2034)
Figure 64. APAC Montelukast Drug Sales Quantity Market Share by Company in 2024
Figure 65. APAC Montelukast Drug Revenue Market Share by Company in 2024
Figure 66. APAC Montelukast Drug Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Montelukast Drug Revenue Market Share by Type (2018-2034)
Figure 68. APAC Montelukast Drug Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Montelukast Drug Revenue Market Share by Application (2018-2034)
Figure 70. APAC Montelukast Drug Revenue Share by Region (2018-2034)
Figure 71. APAC Montelukast Drug Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 76. India Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Montelukast Drug Sales Quantity Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Montelukast Drug Revenue Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Montelukast Drug Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Montelukast Drug Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Montelukast Drug Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Montelukast Drug Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Montelukast Drug Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Montelukast Drug Revenue Share by Country (2018-2034)
Figure 85. Brazil Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Montelukast Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Montelukast Drug Value Chain
Figure 91. Montelukast Drug Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed